There was no device available for analysis; therefore, no physical or visual analysis of the product could be performed.The reported patient symptoms are a known risk associated with implant of these devices as indicated in the instructions for use.Based on the information available, a conclusion code of known inherent risk of device was assigned to this investigation.B3 date of event: approximated.
|
It was reported that the patient underwent a rezum procedure, with the catheter removed two days later.However, another two days later, the patient required catheter placement again, which remained in situ for five days until its removal.The following day, the patient was able to void successfully.However, the day later, the patient experienced urinary retention and sought medical attention at the emergency room.Subsequently, the patient was catheterized for two days and was then admitted to the hospital due to continued urinary difficulties attributed to bladder spasms.While hospitalized, the patient received intravenous antibiotics, including levaquin and septra, despite testing negative for urinary tract infection.Then, the patient was discharged and had a ct scan which indicated the patient had a collapsed bladder.The patient is currently having urine retention and self-catheterizing 3-5 times a day on flomax.The patient started seeing another dr and is having a urodynamic test soon.No further information was provided.
|